XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock Voting
Additional Paid In Capital
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Retained Earnings
Beginning balance, common stock (in shares) at Mar. 31, 2022   126,425,383        
Beginning balance at Mar. 31, 2022 $ 2,060,395 $ 126 $ 3,023,403 $ 141 $ (1,373,840) $ 410,565
Beginning balance, treasury stock (in shares) at Mar. 31, 2022         52,323,090  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (7,132)         (7,132)
Unrealized net investment losses (11)     (11)    
Unrealized net gain (loss) on derivative financial instruments (26)     (26)    
Cumulative translation adjustments (251)     (251)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   946,430        
Issuance of common stock pursuant to vesting of restricted stock units 1 $ 1        
Stock-based compensation expense for restricted stock units granted to employees 14,760   14,760      
Repurchase of treasury stock (in shares)         3,564,902  
Repurchase of treasury stock (160,847)   (45,000)   $ (115,847)  
Ending balance, common stock (in shares) at Jun. 30, 2022   127,371,813        
Ending balance at Jun. 30, 2022 1,906,889 $ 127 2,993,163 (147) $ (1,489,687) 403,433
Ending balance, treasury stock (in shares) at Jun. 30, 2022         55,887,992  
Beginning balance, common stock (in shares) at Mar. 31, 2022   126,425,383        
Beginning balance at Mar. 31, 2022 $ 2,060,395 $ 126 3,023,403 141 $ (1,373,840) 410,565
Beginning balance, treasury stock (in shares) at Mar. 31, 2022         52,323,090  
Ending balance, common stock (in shares) at Mar. 31, 2023 71,249,045 128,683,824        
Ending balance at Mar. 31, 2023 $ 2,029,649 $ 128 3,099,698 5,738 $ (1,546,128) 470,213
Ending balance, treasury stock (in shares) at Mar. 31, 2023 57,434,779       57,434,779  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (4,200)         (4,200)
Unrealized net investment losses (106)     (106)    
Unrealized net gain (loss) on derivative financial instruments 103     103    
Cumulative translation adjustments 68     68    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   1,332,217        
Issuance of common stock pursuant to vesting of restricted stock units 2 $ 2        
Stock-based compensation expense for restricted stock units granted to employees 19,100   19,100      
Repurchase of treasury stock (in shares)         435,172  
Repurchase of treasury stock $ (13,406)     $ (13,406)  
Ending balance, common stock (in shares) at Jun. 30, 2023 72,146,090 130,016,041        
Ending balance at Jun. 30, 2023 $ 2,031,210 $ 130 $ 3,118,798 $ 5,803 $ (1,559,534) $ 466,013
Ending balance, treasury stock (in shares) at Jun. 30, 2023 57,869,951       57,869,951